Annual D&A
$7.10 M
+$832.00 K+13.28%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual depreciation & amortization is $7.10 million, with the most recent change of +$832.00 thousand (+13.28%) on December 31, 2023.
- During the last 3 years, RCKT annual D&A has risen by +$848.00 thousand (+13.57%).
- RCKT annual D&A is now at all-time high.
Performance
RCKT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.39 M
+$18.00 K+0.76%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly depreciation & amortization is $2.39 million, with the most recent change of +$18.00 thousand (+0.76%) on September 30, 2024.
- Over the past year, RCKT quarterly D&A has increased by +$630.00 thousand (+35.82%).
- RCKT quarterly D&A is now -58.34% below its all-time high of $5.74 million, reached on December 31, 2020.
Performance
RCKT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$8.95 M
+$630.00 K+7.57%
September 30, 2024
Summary
- As of February 8, 2025, RCKT TTM depreciation & amortization is $8.95 million, with the most recent change of +$630.00 thousand (+7.57%) on September 30, 2024.
- Over the past year, RCKT TTM D&A has increased by +$2.01 million (+28.93%).
- RCKT TTM D&A is now at all-time high.
Performance
RCKT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RCKT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | +35.8% | +28.9% |
| 3 y3 years | +13.6% | +35.8% | +28.9% |
| 5 y5 years | +2050.9% | +35.8% | +28.9% |
RCKT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.1% | -25.0% | +83.5% | at high | +66.5% |
| 5 y | 5-year | at high | +1566.2% | -58.3% | +2265.3% | at high | +2000.7% |
| alltime | all time | at high | -100.0% | -58.3% | -100.0% | at high | -100.0% |
Rocket Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.39 M(+0.8%) | $8.95 M(+7.6%) |
| Jun 2024 | - | $2.37 M(+5.2%) | $8.32 M(+8.3%) |
| Mar 2024 | - | $2.25 M(+16.5%) | $7.68 M(+8.2%) |
| Dec 2023 | $7.10 M(+13.3%) | $1.94 M(+10.0%) | $7.10 M(+2.3%) |
| Sep 2023 | - | $1.76 M(+1.6%) | $6.94 M(+2.0%) |
| Jun 2023 | - | $1.73 M(+3.5%) | $6.80 M(+2.5%) |
| Mar 2023 | - | $1.67 M(-5.9%) | $6.64 M(+5.9%) |
| Dec 2022 | $6.27 M(+16.6%) | $1.78 M(+9.8%) | $6.27 M(-18.3%) |
| Sep 2022 | - | $1.62 M(+3.4%) | $7.67 M(+11.8%) |
| Jun 2022 | - | $1.57 M(+20.3%) | $6.86 M(+14.3%) |
| Mar 2022 | - | $1.30 M(-59.1%) | $6.00 M(+11.7%) |
| Dec 2021 | $5.37 M(-14.0%) | $3.19 M(+294.2%) | $5.37 M(-32.2%) |
| Sep 2021 | - | $808.00 K(+14.4%) | $7.92 M(+7.2%) |
| Jun 2021 | - | $706.00 K(+4.7%) | $7.39 M(+8.6%) |
| Mar 2021 | - | $674.00 K(-88.2%) | $6.81 M(+8.9%) |
| Dec 2020 | $6.25 M(+1367.1%) | $5.74 M(+2000.7%) | $6.25 M(+914.6%) |
| Sep 2020 | - | $273.00 K(+120.2%) | $616.00 K(+32.8%) |
| Jun 2020 | - | $124.00 K(+5.1%) | $464.00 K(+5.0%) |
| Mar 2020 | - | $118.00 K(+16.8%) | $442.00 K(+3.8%) |
| Dec 2019 | $426.00 K | $101.00 K(-16.5%) | $426.00 K(+0.9%) |
| Sep 2019 | - | $121.00 K(+18.6%) | $422.00 K(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $102.00 K(0.0%) | $377.00 K(+2.2%) |
| Mar 2019 | - | $102.00 K(+5.2%) | $369.00 K(+11.8%) |
| Dec 2018 | $330.00 K(+65.0%) | $97.00 K(+27.6%) | $330.00 K(+13.4%) |
| Sep 2018 | - | $76.00 K(-19.1%) | $291.00 K(+5.4%) |
| Jun 2018 | - | $94.00 K(+49.2%) | $276.00 K(+17.4%) |
| Mar 2018 | - | $63.00 K(+8.6%) | $235.00 K(+17.5%) |
| Dec 2017 | $200.00 K(+18.3%) | $58.00 K(-4.9%) | $200.00 K(0.0%) |
| Sep 2017 | - | $61.00 K(+15.1%) | $200.00 K(+12.4%) |
| Jun 2017 | - | $53.00 K(+89.3%) | $178.00 K(+11.3%) |
| Mar 2017 | - | $28.00 K(-51.7%) | $160.00 K(-5.3%) |
| Dec 2016 | $169.00 K(+275.6%) | $58.00 K(+48.7%) | $169.00 K(+13.4%) |
| Sep 2016 | - | $39.00 K(+11.4%) | $149.00 K(+28.4%) |
| Jun 2016 | - | $35.00 K(-5.4%) | $116.00 K(+41.5%) |
| Mar 2016 | - | $37.00 K(-2.6%) | $82.00 K(+82.2%) |
| Dec 2015 | $45.00 K(>+9900.0%) | $38.00 K(+533.3%) | $45.00 K(+542.9%) |
| Sep 2015 | - | $6000.00(+500.0%) | $7000.00(+600.0%) |
| Jun 2015 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00(-100.0%) | - | - |
| Dec 2012 | $9000.00 | - | - |
FAQ
- What is Rocket Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual D&A year-on-year change?
- What is Rocket Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly D&A year-on-year change?
- What is Rocket Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM D&A year-on-year change?
What is Rocket Pharmaceuticals annual depreciation & amortization?
The current annual D&A of RCKT is $7.10 M
What is the all time high annual D&A for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual depreciation & amortization is $7.10 M
What is Rocket Pharmaceuticals annual D&A year-on-year change?
Over the past year, RCKT annual depreciation & amortization has changed by +$832.00 K (+13.28%)
What is Rocket Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of RCKT is $2.39 M
What is the all time high quarterly D&A for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly depreciation & amortization is $5.74 M
What is Rocket Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, RCKT quarterly depreciation & amortization has changed by +$630.00 K (+35.82%)
What is Rocket Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of RCKT is $8.95 M
What is the all time high TTM D&A for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM depreciation & amortization is $8.95 M
What is Rocket Pharmaceuticals TTM D&A year-on-year change?
Over the past year, RCKT TTM depreciation & amortization has changed by +$2.01 M (+28.93%)